Cincinnati Children's Hospital Medical Center Logo

Gamble Program for Clinical Studies

Loading...

Overview

"Children's Awarded $23.7 Million NIH Contract"

Cincinnati Children's Hospital Medical Center has received a seven-year, $23.7 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), as one of eight Vaccine and Treatment Evaluation Units (VTEUs) in the United States.

The contract is among the largest contracts or grants that Cincinnati Children's has ever received.  Learn more.

A program within the Infectious Diseases Division at Cincinnati Children's Hospital Medical Center, the Gamble Program for Clinical Studies is responsible for the management of the clinical trials program. The emphasis of the clinical trials is on vaccines and antivirals. The studies include all ages, from infants to the elderly.

The Infectious Diseases Division is actively involved in clinical care, teaching, service to professional and academic communities and research.

More Information
Important information for H1N1 vaccine study participants: Public Readiness and Emergency Preparedness Act (PREP Act)
Learn more about the H1N1 Influenza Virus (Swine Flu)

Contact Us

For more information, please contact the Gamble Program for Clinical Research (gambleprogram@cchmc.org) at Cincinnati Children's, 513-636-7699.